Single center experience: midterm functional outcome of knee megaprosthesis after sarcoma resection

Ahmed Alaaeldin; Awad E. Rafalla; Mohamed Aboheif; Albraa Ahmed Abbadi; Ahmed Dwyer; Saed Shekedaf

doi:10.18203/issn.2455-4510.IntJResOrthop20262325

Authors

Ahmed Alaaeldin Department of Orthopaedic Surgery and Traumatology, Elhadra University Hospital, Alexandria, Egypt
Awad E. Rafalla Department of Orthopaedic Surgery and Traumatology, Elhadra University Hospital, Alexandria, Egypt
Mohamed Aboheif Department of Orthopaedic Surgery and Traumatology, Elhadra University Hospital, Alexandria, Egypt
Albraa Ahmed Abbadi Department of Orthopaedic Surgery and Traumatology, Elhadra University Hospital, Alexandria, Egypt
Ahmed Dwyer Department of Orthopaedic Surgery and Traumatology, Elhadra University Hospital, Alexandria, Egypt
Saed Shekedaf Department of Orthopaedic Surgery and Traumatology, Elhadra University Hospital, Alexandria, Egypt

DOI:

https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20262325

Keywords:

Endoprosthetic, Sarcoma resection, Limb salvage

Abstract

Background: Endoprosthetic reconstruction following bone tumor resection is a well-known and popular method for preserving limbs. Endoprosthetic functional outcomes following reconstructions have been the topic of numerous studies the majority of which used subjective parameters like the Musculoskeletal tumor society (MSTS) score.

Methods: A retrospective consecutive sampling strategy was used, and all eligible patients with knee tumours treated at Nariman hospital between 2020 and 2023 were identified from medical records and included. Due to the rarity of knee tumours and the limited annual case volume of approximately 8-10 cases, no formal a priori sample size calculation was performed. The final cohort consisted of all available eligible cases during the study period (n=40). Patients were followed for functional outcomes at 6 months, 1 year, and 2 years, with an average follow-up duration of 38 months (range: 30-71 months). Cases with failure, infection, local recurrence, death, or unavailable functional follow-up were reported separately in the attrition/outcome flow.

Results: The functional outcome of knee tumor prosthesis was excellent with mean functional score for all patients were 68.71%. The mean functional score for distal femur patients was 71.94% while the mean functional score for proximal tibia cases was 63.85%. Younger patients with distal femur lesions showed better functional score, also patients with early management and early post-operative mobilization showed better results. The prosthesis survival was 90%.

Conclusions: Limb salvage surgeries are complex surgeries which need multidisciplinary teamwork. Tumor endoprosthesis is the best option for limb reconstruction following tumor excision around the knee joint allowing early mobilization with low rate of infection and local recurrence.

Author Biography

Ahmed Dwyer, Department of Orthopaedic Surgery and Traumatology, Elhadra University Hospital, Alexandria, Egypt

Department of orthopaedic surgery and traumatology, El Hadara university hospital, Alexandria, Egypt.

References

Ahlmann ER, Menendez LR, Kermani C, Gotha H. Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb. J Bone Joint Surg Br. 2006;88(6):790-5.

Anninga JK, Gelderblom H, Fiocco M, Kroep JR, Taminiau AHM, Hogendoorn PCW, et al. Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?. Eur J Cancer. 2011;47(16):2431-45.

Bacci G, Ferrari S, Bertoni F, Longhi A, Bacchini P, Ruggieri P, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 protocol: an updated report. J Clin Oncol. 2000;18(24):4016-27.

Do Kim J, Kim CK, Chung SH. Outcome of tumor prosthetic reconstruction in osteosarcoma patient. J Korean Bone Joint Tumor Soc. 2011;17(2):79-86.

Gerrand C, Athanasou N, Brennan B, Grimer R, Judson I, Morland B, et al. British Sarcoma Group. UK guidelines for the management of bone sarcomas. Clin Sarcoma Res. 2016;6:7.

Grimer RJ, Sommerville S, Warnock D, Carter SR, Tillman RM, Abudu A, et al. Management and outcome after local recurrence of osteosarcoma. Eur J Cancer. 2005;41(4):578-87.

Levin AS, Arkader A, Morris CD. Reconstruction following tumor resections in skeletally immature patients. J Am Acad Orthop Surg. 2017;25(3):204-13.

Li WX, Ye ZM, Yang DS, Tao HM, Lin N, Yang ZM. Endoprosthetic reconstruction after wide resection of primary bone tumor around the knee. Zhonghua Wai Ke Za Zhi. 2007;45(10):665-8.

Nimi R, Matsumine A, Hamaguchi T, Nakamura T, Uchida A, Sudo A. Prosthetic limb salvage surgery for bone and soft tissue tumors around the knee. Oncol Rep. 2012;28(6):1984-90.

Pang CG, Yang XG, Zhao YL, Liu YC, Hu YC. A novel tool for predicting the survival of endoprosthesis used for reconstruction of the knee following tumor resection: a retrospective cohort study. BMC cancer. 2021;21:1-7.

Sharil AR, Nawaz AH, Azman MN, Zulmi W, Faisham WI. Early functional outcome of resection and endoprosthesis replacement for primary tumor around the knee. Malays Orthop J. 2013;7(1):30.

Stitzlein RN, Wojcik J, Sebro RA, Balamuth NJ, Weber KL. Team approach: osteosarcoma of the distal part of the femur in adolescents. JBJS Rev. 2017;5(12):e5.

Zeegen EN, Aponte-Tinao LA, Hornicek FJ, Gebhardt MC, Mankin HJ. Survivorship analysis of 141 modular metallic endoprostheses at early followup. Clin Orthop Relat Res. 2004;420:239-50.

Zhang C, Hu J, Zhu K, Cai T, Ma X. Survival, complications and functional outcomes of cemented megaprostheses for high-grade osteosarcoma around the knee. Int Orthop. 2018;42:927-38.